HR5343Referred to Committee

Ensuring Patient Access to Critical Breakthrough Products Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-09-15
Introduced
60
Cosponsors
HR
ⓘ
Type

Sponsor

Blake D. Moore
Blake D. Moore
Republican · UT · Representative
Votes with party: 97.9% (606 recorded votes)

Full profile: /officials/M001213

Source: Congress.gov · FEC

Cosponsors (60)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3.

2025-09-17

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill would make it easier for patients to access new breakthrough medications and medical treatments by streamlining the approval process and reducing regulatory barriers at the FDA. The legislation aims to help patients with serious or life-threatening conditions get faster access to promising new drugs and devices that show potential to treat their diseases. The bill affects pharmaceutical companies, patients, healthcare providers, and the FDA's approval procedures.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.